investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Cancer fight ↓5.46   Disease: Oncology ↓5.46   Gene and cell ↓4.53 «See more»   Immunology ↓3.35   Biopharma ↓1.16   Country: China ↓1.16

T cell-based stock segment: trending tickers

IOVA Iovance Biotherapeutics, Inc. - Common Stock -4.53% down -3.56% -0.97 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1425205/000110465924043158/0001104659-24-043158-index.htm
8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
+ My List
CNTB Connect Biopharma Holdings Limited - American Depositary Shares -1.16% down -1.04% -0.12 + Biopharma, Country: China, T cell-based

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1582554/000149315224013255/0001493152-24-013255-index.htm
8-K - Matinas BioPharma Holdings, Inc. (0001582554) (Filer)
+ My List
LVTX LAVA Therapeutics N.V. - Ordinary Shares -6.39% down -5.99% -0.4 + T cell-based, Cancer fight, Medicine, Disease: Oncology

Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1840748/000155837024003667/0001558370-24-003667-index.htm
6-K - LAVA Therapeutics NV (0001840748) (Filer)
+ My List
BTMD Biote Corp. - Class A common stock -2.16% up -2.17% 0.0099999999999998 + T cell-based, Biotechnology, Immunology, Medicine
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.